Israeli Company Hopes To Revolutionize Treatment Of Diabetes

Status
Not open for further replies.

Northerner

Admin (Retired)
Relationship to Diabetes
Type 1
An insulin pill. That’s what Oramed Pharmaceuticals, a small Israeli-based company, hopes to offer millions of diabetics by 2016.

“Oral insulin does not exist in the world today, but we are the furthest advanced in getting it into the market,” said Nadav Kidron, CEO of Oramed. “We are just about to start a Phase 2 trial in the United States, which is big news.”

Oramed already completed a successful Phase 2 trial in South Africa in May 2010, but approval by the U.S.’s Food and Drug Administration (FDA) is the gold standard in the world of pharmaceuticals. To attain FDA approval, Oramed hopes to start Phase 2 trials in the U.S. by early 2013, and, if successful, Phase 3 trials approximately a year later.

http://www.jewishpress.com/news/isr...volutionize-treatment-of-diabetes/2012/07/18/

Still don't understand how it will work :confused: How could you adjust/fine tune the dose? Or would you have one pill=one unit?
 
Last edited:
Status
Not open for further replies.
Back
Top